復宏漢霖-B(02696.HK)與克隆高技術訂立框架物業租賃協議
格隆匯12月31日丨復宏漢霖-B(02696.HK)發佈公告,2019年12月31日,公司與克隆高技術訂立框架物業租賃協議,據此,集團已同意向克隆高技術租用物業,期限自2020年1月1日起至2022年12月31日止。
將予租賃的物業位於上海市宜山路1289號克隆科技園區。具體將予租賃區域將於根據框架物業租賃協議的條款及條件訂立的單獨租賃協議中釐定,有效期三年。
公告表示,公司訂立租賃協議以不時作為其生產基地、實驗室及╱或辦公室用途。由於公司於中國大陸的主要營業地點位置鄰近該等物業,且克隆高技術提供的條款屬正常商業條款,公司自注冊成立以來已向克隆高技術租用物業多年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.